Related Experiment Video
Updated: May 23, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
MKP-1 antagonizes C/EBPβ activity and lowers the apoptotic threshold after ischemic injury
A Rininger1, C Dejesus, A Totten
1Department of Pediatrics, University of Rochester Medical Center, NY, USA.
Abstract:
The dual specificity phosphatase MAPK phosphatase-1 (MKP-1) feeds back on MAP kinase signaling to regulate metabolic, inflammatory and survival responses. MKP-1 is widely expressed in the central nervous system (CNS) and induced after ischemic stress, although its function in these contexts remains unclear. Here we report that MKP-1 activated several cell death factors, including BCL2 and adenovirus E1B 19 kDa interacting protein 3, and caspases 3 and 12 culminating in apoptotic cell death in vitro. MKP-1 also exerted inhibitory effects on the bZIP transcription factor CCAAT/enhancer-binding protein (C/EBPβ), previously shown to have neuroprotective properties. These effects included reduced expression of the full-length C/EBPβ variant and hypo-phosphorylation at the MEK-ERK1/2-sensitive Thr(188) site. Notably, enforced expression C/EBPβ rescued cells from MKP-1-induced toxicity. Studies performed in knock-out mice indicate that the MKP-1 activity is required to exclude C/EBPβ from the nucleus basally, and that MKP-1 antagonizes C/EBPβ expression after global forebrain ischemia, particularly within the vulnerable CA1 sector of the hippocampus. Overall, MKP-1 appears to lower the cellular apoptotic threshold by inhibiting C/EBPβ and enhancing both BH3 protein expression and cellular caspase activity. Thus, although manipulation of the MKP-1-C/EBPβ axis could have therapeutic value in ischemic disorders, our observations using MKP-1 catalytic mutants suggest that approaches geared towards inhibiting MKP-1's phosphatase activity alone may be ineffective.
Insights
MAPK phosphatase-1 (MKP-1) promotes cell death in the central nervous system by inhibiting the neuroprotective factor C/EBPβ. Targeting this MKP-1 and C/EBPβ interaction may offer therapeutic strategies for ischemic disorders.
Area of Science:
- Neuroscience
- Molecular Biology
- Cell Biology
Background:
- MAPK phosphatase-1 (MKP-1) regulates MAP kinase signaling and is present in the central nervous system (CNS), but its role in ischemic stress is not fully understood.
- MKP-1 influences metabolic, inflammatory, and survival pathways, and its induction post-ischemia suggests a critical function in neuronal response.
Purpose of the Study:
- To investigate the function of MKP-1 in the CNS, particularly its role in neuronal cell death and its interaction with neuroprotective factors.
- To elucidate the molecular mechanisms by which MKP-1 affects cell survival and death pathways.
Main Methods:
- In vitro studies assessing MKP-1's effects on cell death factors (BCL2,')} protein 3, caspases 3 and 12) and CCAAT/enhancer-binding protein beta (C/EBPβ).
- Analysis of C/EBPβ expression and phosphorylation in response to MKP-1.
- Rescue experiments using enforced C/EBPβ expression.
- Studies in MKP-1 knockout mice to evaluate MKP-1's role in basal C/EBPβ localization and its response to global forebrain ischemia.
Main Results:
- MKP-1 induced apoptotic cell death in vitro by activating cell death factors and caspases.
- MKP-1 inhibited C/EBPβ, reducing its expression and phosphorylation at a key site.
- Enforced C/EBPβ expression protected cells from MKP-1-induced toxicity.
- MKP-1 activity was necessary for excluding C/EBPβ from the nucleus and antagonized C/EBPβ expression after ischemia, especially in the hippocampus.
- MKP-1 lowers the apoptotic threshold by inhibiting C/EBPβ and increasing BH3 protein and caspase activity.
Conclusions:
- MKP-1 promotes neuronal cell death by inhibiting the neuroprotective transcription factor C/EBPβ.
- The MKP-1-C/EBPβ axis is a critical regulator of apoptosis in the CNS following ischemic injury.
- Targeting the MKP-1-C/EBPβ interaction may hold therapeutic potential for ischemic disorders, but inhibiting MKP-1's phosphatase activity alone might be insufficient.
More Related Videos
Related Concept Videos
The Intrinsic Apoptotic Pathway
MAPK Signaling Cascades
The Extrinsic Apoptotic Pathway
cAMP-dependent Protein Kinase Pathways
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

